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In the last 5 years, there has been a resur-
gence ofinternational interest in research on
exposure to DDT (dichlorodiphenyl tri-
cholorethane) as apossible avoidable causeof
breast cancer. Due to the estrogenic activity
of DDT (1), it has recently been proposed
that this compound acts as a xenoestrogen
that increases the risk of breast cancer in
women who are not necessarily exposed in
an occupational environment. Given the
tremendous public interest in breast cancer,
developing effective research strategies in this
area is a real challenge for environmental
health researchers. Current evidence suggests
that exposure to DDT may elevate the risk
ofdeveloping breast cancer. So far that evi-
dence remains tantalizingly incomplete
(2-5).
Based on research carried out in popula-
tions occupationally exposed to DDT, it
has also been suggested that DDT could
play an important role in the etiology of
pancreatic cancer (6) and leukemias (7-9),
aswell as producing alterations in reproduc-
tive function, such as decreases in sperm
count (10), increases in the frequencies of
preterm births (11,12) and congenital mal-
formations (13), and decreases in the dura-
tion oflactation (14).
Since the 1940s, DDT has been widely
used throughout the world to combat agri-
cultural pests, indoor insects, and in sanita-
tion campaigns against malaria. At present
its use has been totally banned in developed
countries due to its persistence (low
biodegradability), accumulation, and bio-
concentration in lipid systems, including
subcutaneous fat, breast tissue, brain, and
adrenal glands (15,16). In Mexico, DDT
application in sanitation campaigns against
malaria began intermittently in 1956 and
has continued systematically since 1960
(17). Currently, the World Health
Organization recommends the use of
DDT for malarial outbreaks, although
public health experts do not uniformly
endorse this use. DDT targets adult insects
and cannot kill larvae. Resistance ofinsects
to DDT has occurredworldwide (18).
Devastating and obvious effects of
DDT onwildlife, such as endangerment of
the American bald eagle and the peregrine
falcon, were the grounds for the banning
ofDDT in the United States in the 1970s.
As ecological levels ofDDT have dropped
in the United States, these previously
endangered species have recovered (19).
More recently, a spill ofthe pesticide dico-
fol (which contained 10% DDT as an
active ingredient) into Lake Apopka,
Florida, has been tied to alterations in the
sex ratio ofalligators and increased defects
in male alligators (20).
Breast cancer is the second cause of
death among Mexican women, with a rate
of 2.8 per 100,000 women in 1994 (21).
Diagnosis ofthis malignant neoplasia gen-
erally occurs when the disease is at stage II
or greater, as is shown in the information
ofthe Mexico Cancer Registry (MCR) for
1989. During 1989, 1521 new cases were
reported to the MCR Only in 2% ofthese
patients was the tumor discovered when it
was still insitu (30 cases) (22).
Exposure to endogenous estrogens is
the risk factor that links most known caus-
es of breast.cancer. Early age at menarche,
late age at menopause, nuliparousness, and
absence of breastfeeding increase lifetime
estrogen exposures and are all associated
with an elevated risk ofbreast cancer (23).
Estrogen replacement therapy in post-
menopausal women and alcohol and satu-
rated fat consumption are factors that have
been inconsistently linked to an increase in
the risk of breast cancer. In spite of the
progress made in knowledge ofthe etiology
of breast cancer, it is estimated that only
30% of breast tumors can be explained by
these factors (24,25).
A number of epidemiological studies
have been carried out to evaluate the associ-
ation between exposure to DDT and breast
cancer. These studies have been conducted
in populations in which DDT use has been
banned for over 27 years and are subject to
a number of methodological limitations
(2-5,26-28).
In this artide, we first present compara-
tive information about the production and
consumption of DDT in Mexico. Second,
we document the levels of accumulated
DDT in blood, adipose tissue, and breast
milk samples from women who reside in
Mexico City, induding data about the lev-
els ofDDT in foods. Finally, we discuss the
methodological limitations ofepidemiologi-
cal studies on breast cancer and DDT,
exploring how these studies may have been
biased toward a certain conclusion about
this possible association. We propose that
given the unusual agricultural exposures
among populations living in urban areas of
Mexico, a number of research studies
should be conducted to clarify whether
DDT is an avoidable cause ofbreast cancer.
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Production and Consumption of
DDT in Mexico and the United
States
After the Second World War (1945), indus-
trial production of DDT began, largely for
the treatment oflice in soldiers. The pro-
duction and consumption patterns ofDDT
have varied substantially between developed
and developing countries. Malaria control
campaigns have been undertaken in both
developed and developing regions.
Agricultural uses have occurred solely in
developing countries. The production and
uses of DDT in Mexico and the United
States are a good example of these differ-
ences (29 ).
In Mexico, production ofDDT by two
firms began in 1959 (Table 1). In the 1960s
in the United States, Rachel Carson's book
Silent Spring (30) generated widespread
concern about the indiscriminate use ofpes-
ticides. Eventually this led to the regulation
ofDDT in 1969 and the ban on domestic
use in the United States in 1972. However,
in Mexico during the same decade, DDT
and other organochlorine pesticides were
widely used, and during the 1971-1984
period, 60,609 tons of these products were
sprayed; DDT accounted for approximately
10% of these products (31). During this
same period, (1971-1984), the capacity for
DDT production in Mexico was 8000 tons
annually, representing between 43% and
45% of the total national capacity for
organochlorine pesticide production (29).
The evolution ofDDT production and
consumption in Mexico between 1971 and
1991 is shown in Figure 1. During the sec-
ond part ofthe 1970s and the beginning of
the 1980s, both production and consump-
tion varied between 3400 and 4100 tons
annually. Between 1982 and 1986, produc-
tion and consumption decreased notably,
almost to zero, although beginning in 1986
production began to grow again and con-
sumption followed in 1987 (31).
The pronounced decrease in produc-
tion and consumption of DDT observed
during the first halfofthe 1980s in Mexico
was principally due to two causes. First, a
severe economic crisis affected Mexico in
1982, which resulted in a drastic drop in
production and commercial activities in the
country. Second, an international trend
reduced the use of organochlorine pesti-
cides, which werewidely recognized to per-
sist in the environment (32). This trend
resulted in restriction of DDT use in offi-
cial Mexican sanitary campaigns, and
therefore a notable decrease in demand and
production ofDDT.
As shown in Figure 2, approximately
226,000 tons of DDT were used in the
Table1. Evolution of DDT use inthe United States and Mexico
Year United States Year Mexico
1945 Use begins 1945 Use begins
1962 Publication of SilentSpring(30) 1959 Production begins
1969 Regulation begins 1960-70 Use spreads
1972 Domestic use banned 1971-84 60,609tons oforganochlorine pesticides,
including 6,061 tons of DDT peryear
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Figure 1. Apparent DDT production and consumption in Mexico, 1975-1991 (31,34).
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Figure 2. The Mexican malaria campaign, 1959-1993.
sprayed are shown (17).
antimalaria campaign during 1971-1993,
averaging 500 g per household sprayed.
Since 1988, malaria incidence has report-
edly decreased by 90%, and the proportion
ofrural towns with blood samples positive
for malaria has decreased by 75%.
However, current use ofDDT in Mexico is
still greater than in other Latin American
countries, as can be seen in Figure 3
(17-33).
To illustrate the widespread production
and marketing of DDT in Mexico, it
should be noted that in 1987 there were
The number of cases of malaria and households
two large firms that produced DDT as an
active ingredient. This product was used in
turn by 23 firms to develop 6 different for-
mulations, resulting in 35 different regis-
tered brands of pesticides sold in the
national market. Currently DDT is pro-
duced in only a few countries; in Mexico
DDT is produced in a single industrial
plant, located in the cityofSalamanca. Less
than 5000 tons ofDDT have been export-
ed from Mexico since 1971 (28,34).
Recently the Mexico Secretary of
Health made a commitment to eliminate
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the use ofDDT and to look for alternatives
for malaria control with technical support
from United States and Canada (35).
DDT Levels in Serum, Adipose
Tissue, and Breast Milk
Due to the lipophilic nature of DDT and
its principal metabolite, dichlorodiphenyl
dichloroethene (DDE), these compounds
have been found in diverse human samples
of serum, adipose tissue, and breast milk.
The half-life of DDT in human adipose
tissue is approximately 7.5 years. The
amount ofserum DDT varies according to
the levels oflipids circulating in the blood.
It has been estimated that the ratio
between levels of DDT in adipose tissue
and blood is 300 to 1. The presence of
DDE levels in organisms is a good biologi-
cal indicator of chronic exposure to DDT
(36).
Information about levels of DDT and
its metabolites in human samples in Mexico
is scarce (Table 2). The results of a study
carried out in 1975 (37) showed that levels
of DDE in abdominal adipose tissue sam-
ples, expressed in parts per million in a lipid
base (pg/g of extractable lipids), ranged
from 2.65 ± 2.35 in 9 adipose tissue samples
from necropsies in the city ofPuebla (locat-
ed in the central region ofMexico) to 18.36
+ 33.27 in 19 similar samples obtained in
the city ofTorreon (located in the northern
part of Mexico). Corresponding levels
detected in 9 samples from biopsies from
Mexico City had a mean value of 6.05 ±
3.49 (37). The results ofanother study car-
ried out in a city on the northern border of
Mexico (Ciudad Juarez) showed that accu-
mulated levels ofDDT and its derivatives in
62 human adipose tissue samples obtained
in 1977 were 20.59 ± 13.18 ppm, and in
1992, Waliszewski et al. (38,39) found
average levels of DDE to be 18.91 ± 23.29
ppm in necropsy tissue from individuals
who had lived in the state ofVeracruz (Gulf
of Mexico). The initial results obtained by
our research team in 1995 showed that the
geometric mean of DDE in adipose breast
tissue samples from 160 women living in
Mexico City is 6.66 ± 1.66 ppb.
Although the representativeness of the
biological samples analyzed in some ofthese
studies can be questioned, these studies sug-
gest that there is a DDT accumulation gra-
dient that is greater in tropical areas and/or
regions with greater agricultural activity
(Veracruz, Torreon, Ciudad Juarez). These
data also show that inhabitants of urban
areas are exposed to DDT (Torreon, Ciudad
Juarez, Puebla, Veracruz, and Mexico City).
Since the end of the 1970s, Mexican
studies have episodically documented the
presence of DDE and total DDT in breast
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Figure 3. DDT use in malaria prevention programs in selected Latin American countries, 1993-1994;
including 100% and 75% formulations. The 1994values are estimated (33).
Table 2. DDE and total DDT levels in Mexican human samples
Anatomic DDE, DDT,
Reference City Sampletype n site mean ± SD (ppm) mean ± SD (ppm)
(37) Torreon Necropsy 19 Abdomen 18.36 ± 33.27 21.47 ± 37.10
Mexico City Biopsy 9 Abdomen 6.05 ± 3.49 8.31 ± 4.95
Puebla Necropsy 9 Abdomen 2.65 ± 2.35 3.4 ± 3.25
(38) Ciudad Juarez Biopsy 62 NR NR 20.59 ± 13.18
(39) Veracruz Necropsy 90 Abdomen 18.91 ± 23.29 24.14 ± 27.88
Thisstudy Mexico City Biopsy 160 Breast 6.66 ± 1.66(ppb, NR
geometric mean)
NR, not reported.
milk, with levels varying between 0.20 and
0.26 mg/kg (ppm) oftotal milk. Thus, lev-
els of DDE in breast milk in Mexico are
two to three times greater than correspond-
ing levels in samples analyzed in the United
States during that same period (40).
Our 1995 study showed that women
living in Mexico City had DDE levels in of
breast milk of0.594 mg/kg in a lipid base.
In contrast, in women living in tropical
Mexico these levels reached an average level
of 5.02 mg/kg, which is extremely high
(Waliszewski et al., submitted). Thus, there
is a 10-fold difference in DDE levels within
Mexico.
As mentioned previously, use of DDT
in Mexico has been restricted to sanitary
campaigns against malaria. These cam-
paigns have been carried out in all states,
except those which are not considered
endemic (Tlaxcala, Mexico City, Baja
California Norte). Despite this, high accu-
mulation levels of DDE have been found
in the biological samples from Mexico City
residents. It is quite likely that exposures to
DDT have occurred in these urban areas
not only from malarial campaigns but also
from other sources, such as lipophilic
foods.
DDT Levels in Foods
According to the information provided by
the Public Health Laboratory of the
Ministry of Health, out of a total of 439
food samples analyzed between February
1993 and March 1995, diverse organochlo-
rine and organophosphate pesticide residues
were found in 146 (unpublished data).
The foods that contained DDT and its
derivatives were principally meats and dairy
products. For example, in 43.5% of the
milk samples analyzed (86/202),p.p'-DDT,
DDE, andp.p'-TDE were found. DDT lev-
els varied widely, from 0.01 ppm to 0.082
ppm. Likewise, in 13 of the 30 meat sam-
ples (30%), DDE and p.p'-DDT were
found at levels from 0.001 ppm to 0.06
ppm. Sixty-eight percent of the milk sam-
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ples and all the meat products came from
states located in the central-southern part of
the country.
Butter samples (345) from the state of
Veracruz (GulfofMexico) were analyzed in
1994. The results showed that DDE levels
did not exceed those recommended by the
World Health Organization (1.25 ppm)
(Waliszewski et al., submitted). The same
authors found that in 192 cows' milk sam-
ples, DDE levels did not exceed the corre-
sponding Food and Agriculture Organiza-
tion recommended level (Waliszewski et al.,
submitted); levels were also acceptable in 53
samples ofbovine liver fat samples from the
same area (41).
Information about residues of DDT
and its derivatives in Mexican foods should
be interpreted with caution. It is possible
that the results described above are not rep-
resentative of the actual DDT contamina-
tion values, since none ofthe samples ana-
lyzed was obtained through probabilistic
sampling methods.
Methodological Limitations of
Epidemiological Studies ofDDT
Exposure and Breast Cancer
A number of articles have discussed the
methodological limitations ofthe eight epi-
demiological studies that have provided
controversial results on DDT exposure and
breast cancer (42). Given the small sample
size of most of these studies, they lacked
the minimum power necessary to detect a
difference, ifone exists, between DDT lev-
els in breast cancer patients and the corre-
sponding levels in women without the dis-
ease. Another criticism has been the lack of
control ofconfounding variables, principal-
ly parity, breastfeeding, and obesity, which
are factors associated both with breast can-
cer incidence and accumulation or elimina-
tion ofDDT from the body.
In addition to these limitations, other
factors could account for some of the dis-
crepancies in the results. For example, dif-
ferent tumor types may have distinct sus-
ceptibilities to xenoestrogens, so that estro-
gen-positive and -negative tumors may
have different etiologies. In addition, levels
of DDT or metabolites can be reported in
either a lipid base or awet base, thus affect-
ingcomparability across the studies.
In the only study that considered the
presence ofestrogenic receptors in patients
with breast cancer (5), a highly significant
difference was found between the levels of
DDE in adipose tissue and serum in women
with breast cancer (cases) and controls with
benign breast disease (x DDE adipose tis-
sue: 2732 ± 2749.9 pg/kg versus 765 ± 52.9
pg/kg, serum: 8.5 pg/l versus 3.5 pg/l). The
groups ofwomen compared were similar in
terms ofage, parity, and weight loss during
the year before diagnosis. However, there
was a greater prevalence of non-breastfeed-
ing among cases (88.9% versus 76.5%). In
spite ofa small sample size (9 cases and 17
controls), the authors estimated an 8.9
times greater breast cancer risk in those
women in whom DDE levels were above
1292 pg/kg in adipose tissue (5).
In contrast, the epidemiological study
with the largest sample size, carried out by
Krieger et al. (24), compared women with
breast cancer and women without the dis-
ease among a cohort established between
1964 and 1971. The 150 cases and con-
trols consisted of50 whites, 50 blacks, and
50 Asian-Americans. Although approxi-
mately 50% ofthe patients with breast can-
cer showed higher DDE levels, the differ-
ence between these levels and those of the
control group was not statistically signifi-
cant. However, when Asian-Americans
were removed from the analysis, a two- to
threefold excess of breast cancer was evi-
dent for blacks and whites with the highest
levels of DDE in the sera. In addition,
there was no information about breastfeed-
ing or the proportion of estrogen-depen-
dent breast tumors. Levels were not adjust-
ed by total lipids, and no information of
DDE levels in adipose tissue was provided,
which is the best way to measure chronic
DDT accumulation. This could have influ-
enced the observed results (43).
A similarly designed study, controlled
for breastfeeding, found that breast cancer
risk was 3.68 times greater in women with
DDE serum levels of 19.1 ng/ml as com-
pared to women with DDE serum levels of
2.0 ng/ml (4). Another study reported that
p,p'-DDE levels in adipose tissue of
women with breast cancer are greater than
corresponding levels in those with benign
breast disease (3).
In a study that compared only nine
samples ofadipose breast tissue from breast
cancer patients and five adipose tissue sam-
ples from women who died in accidents,
greater concentrations of o,p'-DDT were
found in the women with breast cancer (2).
Finally, two more studies with the same
type of limitations mentioned earlier did
not report higher levels of DDT or its
metabolites in women with breast cancer in
comparison to women without the disease
(26,27).
It is difficult to conclude whether expo-
sure to DDT contributes to an increase in
breast cancer. All ofthe recent studies have
yielded evidence of a dose-response rela-
tionship, although these are subject to
interpretation. There is an evident need for
additional investigations that surmount the
methodological limitations described here.
Conclusions
Many questions about DDT exposure and
its potential impact on health are being
researched at a number oflevels. In terms of
biomedical research, knowledge should be
generated about the possible carcinogenic
mechanisms ofDDE in humans. Also, data
are lackingabout the levels ofDDT accumu-
lation in adipose tissue and serum, as well as
rates of elimination of this compound in
breast milk, in representative populations in
developed and developing countries. High-
risk populations have been identified, princi-
pally in urban and agricultural areas. In
Mexico there is a need to develop systematic
and representative data on DDT contamina-
tion of foods, which will probably explain
the high levels found in human samples.
Identification and assessment of less
toxic and less persistent alternatives for con-
trolling malaria and educational, popula-
tion-based interventions to reduce DDT
exposure both in the work environment
and among the general population are also
needed. These interventions could be
directed toward promoting use ofprotective
gear by workers and health education for
populations not occupationally exposed.
The continuing epidemiological study
being carried out by the National Institute of
Public Health of Mexico, which seeks to
evaluate the association between DDE accu-
mulation levels in serum and adipose tissue
and breast cancer in Mexican women, is
promising in terms of its methodological
characteristics. These characteristics indude
sufficient statistical power (150 cases and
300 controls), a wide range of DDT expo-
sure, control of confounding reproductive
and dietary variables, assessment of DDT
and DDE levels in lipid base, and informa-
tion about estrogenic receptors in asubgroup
ofthe cancer patients.
Efforts should continue to find alterna-
tives to DDT while additional study results
about its role in breast cancer are generated.
Evidence on the long-term ecological conse-
quences of DDT for wildlife are indis-
putable. The absence ofclear-cut proofthat
DDT causes breast cancer should not be
used as an excuse for further delays in phas-
ing out this persistent, toxic organic pollu-
tant. As many ofthe known causes ofbreast
cancer cannot readily be altered, those caus-
es that can be controlled become all the
more important forpublic health.
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